id	sid	eid	entity	type
ajlm-2415	1	1	clinton van der westhuizen division	PERSON
ajlm-2415	1	2	stellenbosch university	ORG
ajlm-2415	1	3	cape town	GPE
ajlm-2415	1	4	south africa	GPE
ajlm-2415	1	5	tygerberg hospital	ORG
ajlm-2415	1	6	national health laboratory service	ORG
ajlm-2415	1	7	cape town	GPE
ajlm-2415	1	8	south africa	GPE
ajlm-2415	1	9	mae	PERSON
ajlm-2415	1	10	stellenbosch university	ORG
ajlm-2415	1	11	cape town	GPE
ajlm-2415	1	12	south africa	GPE
ajlm-2415	1	13	tygerberg hospital	ORG
ajlm-2415	1	14	national health laboratory service	ORG
ajlm-2415	1	15	cape town	GPE
ajlm-2415	1	16	south africa	GPE
ajlm-2415	1	17	pieter nel division	ORG
ajlm-2415	1	18	stellenbosch university	ORG
ajlm-2415	1	19	cape town	GPE
ajlm-2415	1	20	south africa	GPE
ajlm-2415	1	21	tygerberg hospital	ORG
ajlm-2415	1	22	national health laboratory service	ORG
ajlm-2415	1	23	cape town	GPE
ajlm-2415	1	24	south africa	GPE
ajlm-2415	1	25	van der westhuizen c	PERSON
ajlm-2415	1	26	newton	ORG
ajlm-2415	1	27	three	CARDINAL
ajlm-2415	1	28	south african	NORP
ajlm-2415	2	1	afr j	PERSON
ajlm-2415	3	1	2024;13(1	CARDINAL
ajlm-2415	4	1	1	CARDINAL
ajlm-2415	4	2	three	CARDINAL
ajlm-2415	4	3	south african	NORP
ajlm-2415	4	4	clinton van der westhuizen	PERSON
ajlm-2415	4	5	mae newton-foot	PERSON
ajlm-2415	4	6	pieter nel	ORG
ajlm-2415	4	7	24 jan. 2024	DATE
ajlm-2415	4	8	29	CARDINAL
ajlm-2415	4	9	20	CARDINAL
ajlm-2415	4	10	aug. 2024	DATE
ajlm-2415	4	11	2024	DATE
ajlm-2415	10	1	multiplex	NORP
ajlm-2415	11	1	three	CARDINAL
ajlm-2415	12	1	forty-eight	CARDINAL
ajlm-2415	12	2	south africa	GPE
ajlm-2415	13	1	2020	DATE
ajlm-2415	13	2	august 2020	DATE
ajlm-2415	14	1	ii rv16	PERSON
ajlm-2415	14	2	2.1	CARDINAL
ajlm-2415	14	3	qiastat-dx®	ORG
ajlm-2415	14	4	qrp	ORG
ajlm-2415	16	1	ii rv16	PERSON
ajlm-2415	16	2	96.6%	PERCENT
ajlm-2415	16	3	57/59	CARDINAL
ajlm-2415	16	4	98.2%	PERCENT
ajlm-2415	16	5	56/57	CARDINAL
ajlm-2415	16	6	qrp	ORG
ajlm-2415	16	7	80.7%	PERCENT
ajlm-2415	16	8	46/57	CARDINAL
ajlm-2415	17	1	99.8%	PERCENT
ajlm-2415	17	2	660/661	CARDINAL
ajlm-2415	17	3	99.0%	PERCENT
ajlm-2415	17	4	704/711	CARDINAL
ajlm-2415	17	5	99.7%	PERCENT
ajlm-2415	18	1	qrp	ORG
ajlm-2415	18	2	41.7%	PERCENT
ajlm-2415	18	3	28.6%	PERCENT
ajlm-2415	18	4	4/14	CARDINAL
ajlm-2415	18	5	88.4%	PERCENT
ajlm-2415	18	6	38/43	CARDINAL
ajlm-2415	19	1	three	CARDINAL
ajlm-2415	19	2	qrp	ORG
ajlm-2415	20	1	multiplex	NORP
ajlm-2415	20	2	african	NORP
ajlm-2415	21	1	multiplex	NORP
ajlm-2415	21	2	anyplex™ ii rv16	LAW
ajlm-2415	21	3	®	ORG
ajlm-2415	21	4	2.1	CARDINAL
ajlm-2415	21	5	qiastat-dx®	ORG
ajlm-2415	22	1	first	ORDINAL
ajlm-2415	22	2	the food and drug administration	ORG
ajlm-2415	22	3	the united states	GPE
ajlm-2415	22	4	2009.7	CARDINAL
ajlm-2415	22	5	multiplex	NORP
ajlm-2415	22	6	one	CARDINAL
ajlm-2415	22	7	multiplex	NORP
ajlm-2415	22	8	south africa	GPE
ajlm-2415	22	9	africa	LOC
ajlm-2415	23	1	2019	DATE
ajlm-2415	23	2	2	CARDINAL
ajlm-2415	23	3	multiplex molecular assays	ORG
ajlm-2415	23	4	crs	ORG
ajlm-2415	24	1	biased.17 tygerberg hospital	ORG
ajlm-2415	24	2	south africa	GPE
ajlm-2415	24	3	ii rv16	PERSON
ajlm-2415	26	1	2.1 plus	CARDINAL
ajlm-2415	26	2	qrp	ORG
ajlm-2415	28	1	multiplex assays	ORG
ajlm-2415	28	2	verigene®	ORG
ajlm-2415	28	3	south african	NORP
ajlm-2415	29	1	multiplex	NORP
ajlm-2415	29	2	africa	LOC
ajlm-2415	29	3	qrp	ORG
ajlm-2415	29	4	south africa	GPE
ajlm-2415	29	5	crs	PRODUCT
ajlm-2415	30	1	the health research ethics committee of stellenbosch university	ORG
ajlm-2415	35	1	qrp	ORG
ajlm-2415	36	1	arv	ORG
ajlm-2415	37	1	crs	ORG
ajlm-2415	37	2	three	CARDINAL
ajlm-2415	38	1	seegene®	ORG
ajlm-2415	38	2	seoul	GPE
ajlm-2415	38	3	south korea	GPE
ajlm-2415	38	4	16	CARDINAL
ajlm-2415	39	1	2	CARDINAL
ajlm-2415	39	2	biomérieux®	ORG
ajlm-2415	39	3	biofire®	PERSON
ajlm-2415	39	4	france	GPE
ajlm-2415	39	5	23	CARDINAL
ajlm-2415	39	6	19	CARDINAL
ajlm-2415	39	7	four	CARDINAL
ajlm-2415	39	8	two	CARDINAL
ajlm-2415	39	9	multiplex rt-pcr	PERSON
ajlm-2415	39	10	45 min	DATE
ajlm-2415	40	1	qrp	ORG
ajlm-2415	40	2	qiagen®	ORG
ajlm-2415	40	3	hilden	GPE
ajlm-2415	40	4	germany	GPE
ajlm-2415	40	5	19	CARDINAL
ajlm-2415	40	6	3	CARDINAL
ajlm-2415	40	7	®	ORG
ajlm-2415	42	1	69 min	TIME
ajlm-2415	43	1	qrp	ORG
ajlm-2415	43	2	1	CARDINAL
ajlm-2415	44	1	firstly	ORDINAL
ajlm-2415	44	2	hku1	ORG
ajlm-2415	44	3	middle east	LOC
ajlm-2415	44	4	two	CARDINAL
ajlm-2415	45	1	arv	ORG
ajlm-2415	46	1	l. pneumophila	PERSON
ajlm-2415	47	1	qrp	ORG
ajlm-2415	47	2	middle east	LOC
ajlm-2415	48	1	forty-eight	DATE
ajlm-2415	48	2	32	CARDINAL
ajlm-2415	48	3	16	CARDINAL
ajlm-2415	49	1	approximately 50	CARDINAL
ajlm-2415	49	2	qrp	ORG
ajlm-2415	50	1	01 may 2020	DATE
ajlm-2415	50	2	31	CARDINAL
ajlm-2415	50	3	south africa	GPE
ajlm-2415	51	1	three	CARDINAL
ajlm-2415	53	1	12 months	DATE
ajlm-2415	53	2	01 april 2021	DATE
ajlm-2415	53	3	qrp	ORG
ajlm-2415	54	1	biomérieux	ORG
ajlm-2415	54	2	nuclisens®	PERSON
ajlm-2415	54	3	france	GPE
ajlm-2415	55	1	the bio-rad®	ORG
ajlm-2415	55	2	redmond	GPE
ajlm-2415	55	3	washington	GPE
ajlm-2415	55	4	united states	GPE
ajlm-2415	57	1	qrp	ORG
ajlm-2415	60	1	qrp	ORG
ajlm-2415	62	1	qrp	ORG
ajlm-2415	63	1	qrp	ORG
ajlm-2415	66	1	crs	ORG
ajlm-2415	67	1	three	CARDINAL
ajlm-2415	68	1	two	CARDINAL
ajlm-2415	68	2	three	CARDINAL
ajlm-2415	69	1	two	CARDINAL
ajlm-2415	69	2	three	CARDINAL
ajlm-2415	70	1	one	CARDINAL
ajlm-2415	71	1	one	CARDINAL
ajlm-2415	73	1	south african	NORP
ajlm-2415	73	2	90%	PERCENT
ajlm-2415	73	3	90%	PERCENT
ajlm-2415	75	1	hku1	ORG
ajlm-2415	75	2	middle east	LOC
ajlm-2415	76	1	crs	PRODUCT
ajlm-2415	77	1	mcnemar	GPE
ajlm-2415	77	2	crs	ORG
ajlm-2415	78	1	48	CARDINAL
ajlm-2415	78	2	qrp	ORG
ajlm-2415	79	1	one	CARDINAL
ajlm-2415	79	2	qrp	ORG
ajlm-2415	79	3	qrp	ORG
ajlm-2415	79	4	3	CARDINAL
ajlm-2415	80	1	thirteen	CARDINAL
ajlm-2415	80	2	27.1%	PERCENT
ajlm-2415	80	3	qrp	ORG
ajlm-2415	81	1	only two	CARDINAL
ajlm-2415	82	1	three	CARDINAL
ajlm-2415	83	1	48	CARDINAL
ajlm-2415	83	2	1	CARDINAL
ajlm-2415	84	1	96.6%	PERCENT
ajlm-2415	84	2	98.2%	PERCENT
ajlm-2415	85	1	qrp	ORG
ajlm-2415	85	2	80.7%	PERCENT
ajlm-2415	86	1	three	CARDINAL
ajlm-2415	86	2	99.0%	PERCENT
ajlm-2415	86	3	99.8%	PERCENT
ajlm-2415	86	4	2	CARDINAL
ajlm-2415	87	1	1	CARDINAL
ajlm-2415	87	2	ii rv16	PERSON
ajlm-2415	87	3	2.1	CARDINAL
ajlm-2415	87	4	48	CARDINAL
ajlm-2415	87	5	south africa	GPE
ajlm-2415	87	6	2021	CARDINAL
ajlm-2415	87	7	2022	CARDINAL
ajlm-2415	88	1	2	CARDINAL
ajlm-2415	88	2	ii rv16	PERSON
ajlm-2415	88	3	2.1	CARDINAL
ajlm-2415	88	4	48	CARDINAL
ajlm-2415	88	5	south africa	GPE
ajlm-2415	88	6	2021	CARDINAL
ajlm-2415	88	7	2022	CARDINAL
ajlm-2415	89	1	27	CARDINAL
ajlm-2415	89	2	56.3%	PERCENT
ajlm-2415	89	3	three	CARDINAL
ajlm-2415	89	4	14	CARDINAL
ajlm-2415	89	5	10	CARDINAL
ajlm-2415	91	1	qrp	ORG
ajlm-2415	91	2	11	CARDINAL
ajlm-2415	91	3	five	CARDINAL
ajlm-2415	91	4	four	CARDINAL
ajlm-2415	92	1	229e	PRODUCT
ajlm-2415	92	2	oc43	PRODUCT
ajlm-2415	92	3	nl63	ORG
ajlm-2415	92	4	less than 60.0%	PERCENT
ajlm-2415	93	1	five	CARDINAL
ajlm-2415	93	2	seven	CARDINAL
ajlm-2415	93	3	88.4%	PERCENT
ajlm-2415	94	1	0.07	CARDINAL
ajlm-2415	95	1	100.0%	PERCENT
ajlm-2415	96	1	seven	CARDINAL
ajlm-2415	96	2	qrp	ORG
ajlm-2415	96	3	qrp	ORG
ajlm-2415	97	1	crs	ORG
ajlm-2415	97	2	qrp	ORG
ajlm-2415	98	1	first	ORDINAL
ajlm-2415	98	2	africa	LOC
ajlm-2415	100	1	qrp	ORG
ajlm-2415	101	1	98.2%	PERCENT
ajlm-2415	101	2	84.5%	PERCENT
ajlm-2415	101	3	2012	DATE
ajlm-2415	101	4	north carolina	GPE
ajlm-2415	101	5	the united states of america	GPE
ajlm-2415	101	6	57.1%	PERCENT
ajlm-2415	101	7	100.0%	PERCENT
ajlm-2415	101	8	arv	ORG
ajlm-2415	101	9	qrp	ORG
ajlm-2415	101	10	83.3%	PERCENT
ajlm-2415	102	1	1.7	CARDINAL
ajlm-2415	102	2	2.1	CARDINAL
ajlm-2415	102	3	2013	DATE
ajlm-2415	102	4	texas	GPE
ajlm-2415	102	5	united states	GPE
ajlm-2415	103	1	five	CARDINAL
ajlm-2415	104	1	88.4%	PERCENT
ajlm-2415	104	2	crs	ORG
ajlm-2415	104	3	0.07	CARDINAL
ajlm-2415	105	1	crs	ORG
ajlm-2415	106	1	two	CARDINAL
ajlm-2415	106	2	south african	NORP
ajlm-2415	107	1	south korea	GPE
ajlm-2415	107	2	2013	DATE
ajlm-2415	107	3	88.8%	PERCENT
ajlm-2415	107	4	100.0%	PERCENT
ajlm-2415	108	1	one	CARDINAL
ajlm-2415	108	2	oc43	PRODUCT
ajlm-2415	108	3	qrp	ORG
ajlm-2415	109	1	hku1	ORG
ajlm-2415	110	1	arv	ORG
ajlm-2415	110	2	hku1	ORG
ajlm-2415	111	1	2018	DATE
ajlm-2415	111	2	singapore	GPE
ajlm-2415	111	3	the last two decades	DATE
ajlm-2415	111	4	2019 pandemic.28	DATE
ajlm-2415	111	5	arv	ORG
ajlm-2415	111	6	only two	CARDINAL
ajlm-2415	111	7	58	CARDINAL
ajlm-2415	111	8	3.4%	PERCENT
ajlm-2415	112	1	seven	CARDINAL
ajlm-2415	112	2	only two	CARDINAL
ajlm-2415	112	3	qrp	ORG
ajlm-2415	114	1	qrp	ORG
ajlm-2415	115	1	qrp	ORG
ajlm-2415	115	2	germany	GPE
ajlm-2415	115	3	2020	DATE
ajlm-2415	115	4	france	GPE
ajlm-2415	115	5	2021	CARDINAL
ajlm-2415	115	6	80.7%	PERCENT
ajlm-2415	115	7	south african	NORP
ajlm-2415	119	1	qrp	ORG
ajlm-2415	120	1	two	CARDINAL
ajlm-2415	120	2	qrp	ORG
ajlm-2415	120	3	1	CARDINAL
ajlm-2415	121	1	33.0	CARDINAL
ajlm-2415	121	2	1	CARDINAL
ajlm-2415	121	3	31.4	CARDINAL
ajlm-2415	122	1	25.7	CARDINAL
ajlm-2415	124	1	qrp	ORG
ajlm-2415	126	1	2019	CARDINAL
ajlm-2415	132	1	multiplex	NORP
ajlm-2415	134	1	qrp	ORG
ajlm-2415	137	1	tonya esterhuizen	PERSON
ajlm-2415	137	2	stellenbosch university	ORG
ajlm-2415	138	1	mathilda claassen	PERSON
ajlm-2415	138	2	national health laboratory service	ORG
ajlm-2415	138	3	tygerberg hospital	ORG
ajlm-2415	138	4	national health laboratory service	ORG
ajlm-2415	138	5	tygerberg hospital	ORG
ajlm-2415	139	1	qrp	ORG
ajlm-2415	139	2	biomérieux®	ORG
ajlm-2415	139	3	biofire®	PERSON
ajlm-2415	139	4	qiagen®	ORG
ajlm-2415	141	1	biomérieux®	ORG
ajlm-2415	141	2	biofire	PERSON
ajlm-2415	142	1	c.v.d.w	PRODUCT
ajlm-2415	143	1	p.n.	PERSON
ajlm-2415	144	1	m.n.-f	DATE
ajlm-2415	146	1	biomérieux®	ORG
ajlm-2415	146	2	biofire®	PERSON
ajlm-2415	146	3	qiagen®	ORG
ajlm-2415	149	1	the national health laboratory service	ORG
ajlm-2415	149	2	tygerberg hospital	ORG
ajlm-2415	149	3	p.n.	GPE
ajlm-2415	153	1	templeton ke	PERSON
ajlm-2415	155	1	j clin virol	PERSON
ajlm-2415	156	1	2007;40	CARDINAL
ajlm-2415	157	1	khalil ia	PERSON
ajlm-2415	157	2	2017	CARDINAL
ajlm-2415	157	3	2017	CARDINAL
ajlm-2415	158	1	lancet respir med.	ORG
ajlm-2415	159	1	2019;7(1):69–89	CARDINAL
ajlm-2415	160	1	kessler hh	PERSON
ajlm-2415	160	2	berger a. verification	PERSON
ajlm-2415	161	1	j clin virol	PERSON
ajlm-2415	162	1	2007;40(2):93–98	ORG
ajlm-2415	163	1	https://doi.org/10.1016/j.jcv.2007.07.009	CARDINAL
ajlm-2415	163	2	eb	ORG
ajlm-2415	163	3	miller	PERSON
ajlm-2415	163	4	rvpv1	PERSON
ajlm-2415	163	5	rvp	PERSON
ajlm-2415	163	6	multiplex	NORP
ajlm-2415	164	1	j clin microbiol	PERSON
ajlm-2415	165	1	2013;51(5	CARDINAL
ajlm-2415	165	2	1528–1533	CARDINAL
ajlm-2415	166	1	https://doi.org/10.1128/jcm.03368-12 chan m	PERSON
ajlm-2415	166	2	jiang b	PERSON
ajlm-2415	166	3	lim pq	PERSON
ajlm-2415	167	1	anyplex ii rv16	PERSON
ajlm-2415	168	1	j clin virol	PERSON
ajlm-2415	169	1	2018;106:13–17	CARDINAL
ajlm-2415	170	1	https://doi.org/10.1016/j.jcv.2018.07.002 parcina m	PERSON
ajlm-2415	170	2	visseaux b	ORG
ajlm-2415	170	3	jozic r	PERSON
ajlm-2415	172	1	plos	PERSON
ajlm-2415	172	2	one	CARDINAL
ajlm-2415	173	1	2020;15	CARDINAL
ajlm-2415	175	1	scand j	PERSON
ajlm-2415	177	1	mcadam aj	PERSON
ajlm-2415	178	1	multiplex	NORP
ajlm-2415	178	2	first	ORDINAL
ajlm-2415	179	1	j clin microbiol	PERSON
ajlm-2415	180	1	2015;53(10):3110–3115	CARDINAL
ajlm-2415	181	1	leber al	PERSON
ajlm-2415	181	2	hansen g	PERSON
ajlm-2415	183	1	j clin micrbiol	PERSON
ajlm-2415	184	1	2020;58(5):e00155-20	DATE
ajlm-2415	185	1	https://doi.org/10.1128/jcm.00155-20 rappo u	PERSON
ajlm-2415	185	2	jenkins sg	PERSON
ajlm-2415	185	3	multiplex pcr	ORG
ajlm-2415	186	1	j clin microbiol	PERSON
ajlm-2415	188	1	https://doi.org/10.1128/jcm.00549-16 hansen gt	PERSON
ajlm-2415	188	2	moore j	PERSON
ajlm-2415	190	1	j clin virol	PERSON
ajlm-2415	192	1	bernstein hh	PERSON
ajlm-2415	192	2	bradley	PERSON
ajlm-2415	193	1	2018	DATE
ajlm-2415	194	1	clin infect dis	ORG
ajlm-2415	195	1	2018;68(6):e1	CARDINAL
ajlm-2415	196	1	https://doi.org/10.1093/cid/ciy866 vandenberg o	PERSON
ajlm-2415	196	2	rochas o	PERSON
ajlm-2415	196	3	van belkum	PERSON
ajlm-2415	196	4	kozlakidis z. considerations	PERSON
ajlm-2415	196	5	covid-19	PERSON
ajlm-2415	197	1	nat rev microbiol	PERSON
ajlm-2415	198	1	2021;19:171–183	CARDINAL
ajlm-2415	199	1	https://doi.org/10.1038/s41579-020-00461-z da silva ferreira bi	PERSON
ajlm-2415	199	2	da silva-gomes nl	PERSON
ajlm-2415	199	3	coelho wldcnp	PERSON
ajlm-2415	199	4	covid-19	ORG
ajlm-2415	200	1	plos one	PERSON
ajlm-2415	201	1	2021;16(11):e0260087	CARDINAL
ajlm-2415	202	1	de groot jah	PERSON
ajlm-2415	206	1	alonzo ta	PERSON
ajlm-2415	206	2	pepe ms	PERSON
ajlm-2415	210	1	baughman al	PERSON
ajlm-2415	210	2	bisgard km	PERSON
ajlm-2415	210	3	cortese mm	PERSON
ajlm-2415	210	4	thompson	PERSON
ajlm-2415	210	5	sanden gn	PERSON
ajlm-2415	212	1	clin vaccine immunol	ORG
ajlm-2415	213	1	2008;15(1):106–114	CARDINAL
ajlm-2415	213	2	seegene® inc	ORG
ajlm-2415	213	3	anyplex™ ii rv16	LAW
ajlm-2415	213	4	multiplex	NORP
ajlm-2415	215	1	2023	CARDINAL
ajlm-2415	215	2	aug 07	DATE
ajlm-2415	216	1	llc	GPE
ajlm-2415	217	1	biofire®	PERSON
ajlm-2415	217	2	2.1 plus	CARDINAL
ajlm-2415	220	1	2022	CARDINAL
ajlm-2415	220	2	2023	CARDINAL
ajlm-2415	220	3	aug 07	DATE
ajlm-2415	221	1	gmbh	PERSON
ajlm-2415	222	1	qiastat-dx®	ORG
ajlm-2415	225	1	2021	CARDINAL
ajlm-2415	225	2	2023	CARDINAL
ajlm-2415	225	3	aug 07	DATE
ajlm-2415	226	1	bateman ac	PERSON
ajlm-2415	226	2	lusaka	GPE
ajlm-2415	226	3	zambia	GPE
ajlm-2415	226	4	2011–2012	CARDINAL
ajlm-2415	227	1	bmc infect dis	ORG
ajlm-2415	228	1	2015;15:52	DATE
ajlm-2415	229	1	du plessis m	PERSON
ajlm-2415	229	2	ndlangisa k	PERSON
ajlm-2415	230	1	south africa	GPE
ajlm-2415	230	2	2017	DATE
ajlm-2415	233	1	https://doi.org/10.1016/j.ijid.2022.06.011	ORG
ajlm-2415	233	2	ma	PERSON
ajlm-2415	233	3	madhi sa	PERSON
ajlm-2415	233	4	cohen c	PERSON
ajlm-2415	234	1	10	CARDINAL
ajlm-2415	234	2	south africa	GPE
ajlm-2415	234	3	2009–2010	DATE
ajlm-2415	236	1	2012;206(suppl 1):s159	DATE
ajlm-2415	237	1	south african	NORP
ajlm-2415	238	1	28	CARDINAL
ajlm-2415	241	1	2021	CARDINAL
ajlm-2415	241	2	jul 30	DATE
ajlm-2415	241	3	2023	CARDINAL
ajlm-2415	241	4	aug 07	DATE
ajlm-2415	242	1	lacey d	PERSON
ajlm-2415	242	2	huang r	PERSON
ajlm-2415	242	3	haag c.	PERSON
ajlm-2415	242	4	1.7	CARDINAL
ajlm-2415	243	1	j clin microbiol	PERSON
ajlm-2415	245	1	https://doi.org/10.1128/jcm.02546-13 kim hk	PERSON
ajlm-2415	245	2	yun ka	PERSON
ajlm-2415	245	3	sung h	ORG
ajlm-2415	245	4	kim mn	PERSON
ajlm-2415	245	5	anyplex ii rv16	PERSON
ajlm-2415	245	6	rv15	PRODUCT
ajlm-2415	246	1	j clin microbiol	PERSON
ajlm-2415	247	1	2013;51(4):1137–1141	DATE
ajlm-2415	248	1	esposito s.	PERSON
ajlm-2415	250	1	2010;16(2):183–188	CARDINAL